Marblegate Capital Corporation MGTE
0.94
(0.06)
(6.00%)
as of 24 Sep
- Market cap
- $406.3M
- P/E
- 41.8×
Follow MGTE
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| 0.21% | (14.88%) | (15.67%) | (18.26%) |
+8 more TTM periods Free account |
|
| 0.37% | (12.01%) | (6.49%) | (15.56%) | ||
ROIC |
(0.96%) | (0.18%) | 0.08% | 0.74% | |
Return on Tangible Assets |
19.66% | (100.55%) | (239.60%) | (184.91%) | |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 38.88 | |
Free Cash Flow per Share |
(0.74) | (0.71) | (0.53) | (0.30) | |
Free Cash Flow |
(54.64) | (52.65) | (37.73) | (22.24) | |
Capital Expenditures |
(46.67) | (45.22) | (38.90) | (21.49) | |
Piotroski F-Score |
0.00 | 1.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(1.23%) | (1.16%) | 0.18% | (0.12%) | |
Accounts Receivable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Accounts Payable Turnover |
0.00 | — | — | — | |
Inventory Turnover |
0.00 | — | — | — | |
Average Days of Payables |
0.00 | — | — | — | |
Days of Inventory on Hand |
0.00 | — | — | — | |
Tax Rate |
(0.67) | (5.47) | (5.37) | (498.13) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
86.00% | 84.65% | 91.47% | 72.02% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
(6.16) | 0.18 | (0.03) | 0.01 | |
Depreciation/Fixed assets |
10.81 | 0.11 | 5.82 | 0.12 | |
Capex/Depreciation |
(7.65) | (10.07) | (11.68) | (8.32) | |
Revenue per Share |
0.77 | 0.79 | 0.68 | 0.67 | |
Operating CF per Share |
(0.11) | (0.10) | 0.02 | (0.01) | |
Capex per Share |
(0.63) | (0.61) | (0.55) | (0.29) | |
Capex to Sales |
0.82 | 0.78 | 0.80 | 0.43 | |
Net Profit Margin |
2.27% | (73.06%) | (92.61%) | (104.13%) |
Columns are period end dates